Johnson and Johnson stops preliminaries because of unexplained ailment in member Kumar Jeetendra | October 13, 2020 Johnson & Johnson said on October 12 it has temporarily paused clinical trials of its own COVID-19 vaccine candidate because of an unexplained illness in a research participant. In a statement, the company said that the participant’s illness has been reviewed and assessed by an independent data and safety monitoring board, and its clinical and …
